The Journal of Immunology, Vol 151, Issue 10 5504-5515, Copyright © 1993 by American Association of Immunologists

ARTICLES

Trypanosoma cruzi acidic ribosomal P protein gene family. Novel P proteins encoding unusual cross-reactive epitopes

YA Skeiky, DR Benson, JA Guderian, PR Sleath, M Parsons and SG Reed
Seattle Biomedical Research Institute, WA 98109.

We have cloned and characterized cDNA molecules that encode members of the acidic ribosomal protein family (TcP proteins) from the protozoan parasite Trypanosoma cruzi. These proteins have been shown to be antigenic in individuals with T. cruzi infection. Unlike other known eukaryotic cells, T. cruzi possesses at least four types of P protein genes TcP0, TcP1, TcP2a, and TcP2b, each of which is present in multiple copies in the genome. These genes are present on at least three different chromosomes. Although the abundance of TcP0, TcP2a, and TcP2b transcripts do not appear to vary among the parasite life-cycle stages, TcP1 is predominantly expressed in the epimastigote (insect) stage. TcP0 has a C-terminal heptapeptide sequence that is similar to those of archaebacterial acidic (P-like) proteins, but the TcP1/P2 proteins terminate with a shared sequence characteristic of the P proteins of higher eukaryotes. The serine residues or other potential phosphorylation sites typically found within the highly charged C- terminal acidic domain are absent in T. cruzi P proteins. Using synthetic peptides, we demonstrated that approximately 80% of T. cruzi- infected individuals produce two distinct but cross-reactive anti-P antibody specificities directed against the C-termini of TcP0 and TcP1/P2. We also expressed the full length (non-fusion) recombinant human P0 and demonstrated that the T. cruzi anti-P antibodies cross- react with the C-terminal residues of human P-proteins. Conversely, human anti-P protein antibodies in sera from patients with SLE cross- react with the C-terminal epitope of T. cruzi TcP1/P2 proteins. The cross-reactivity of anti-TcP antibodies with human P proteins suggests that, through antigenic conservation, TcP proteins may contribute to the development of autoreactive antibodies in Chagas' disease patients.

This article has been cited by other articles:

				S. Aguirre, A. M. Silber, M. E. F. Brito, M. E. Ribone, C. M. Lagier, and I. S. Marcipar Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection. J. Clin. Microbiol., October 1, 2006; 44(10): 3768 - 3774. [Abstract] [Full Text] [PDF]

				M. Lesenechal, L. Becquart, X. Lacoux, L. Ladaviere, R. C. P. Baida, G. Paranhos-Baccala, and J. F. da Silveira Mapping of B-Cell Epitopes in a Trypanosoma cruzi Immunodominant Antigen Expressed in Natural Infections Clin. Vaccine Immunol., February 1, 2005; 12(2): 329 - 333. [Abstract] [Full Text] [PDF]

				P. Sepulveda, P. Liegeard, G. Wallukat, M. J. Levin, and M. Hontebeyrie Modulation of Cardiocyte Functional Activity by Antibodies against Trypanosoma cruzi Ribosomal P2 Protein C Terminus Infect. Immun., September 1, 2000; 68(9): 5114 - 5119. [Abstract] [Full Text] [PDF]

				D. Kaplan, I. Ferrari, P. L. Bergami, E. Mahler, G. Levitus, P. Chiale, J. Hoebeke, M. H. V. Van Regenmortel, and M. J. Levin Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus PNAS, September 16, 1997; 94(19): 10301 - 10306. [Abstract] [Full Text] [PDF]